v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| OPERATING EXPENSES- | ||||
| RESEARCH AND DEVELOPMENT EXPENSES | $ 2,175,245 | $ 2,563,469 | $ 3,661,633 | $ 4,306,520 |
| SELLING, GENERAL AND ADMINISTRATIVE EXPENSES | 2,550,848 | 2,242,658 | 4,538,657 | 4,147,729 |
| Total operating expenses | 4,726,093 | 4,806,127 | 8,200,290 | 8,454,249 |
| OPERATING LOSS | (4,726,093) | (4,806,127) | (8,200,290) | (8,454,249) |
| OTHER INCOME (EXPENSE), NET | ||||
| Interest income | 45,243 | 0 | 96,253 | 0 |
| Interest expense | (716,814) | (124,075) | (740,251) | (298,812) |
| Total other income (expense), net | (671,571) | (124,075) | (643,998) | (298,812) |
| LOSS BEFORE INCOME TAXES | (5,397,664) | (4,930,202) | (8,844,288) | (8,753,061) |
| Income tax expense | 0 | 0 | 0 | 0 |
| NET LOSS | (5,397,664) | (4,930,202) | (8,844,288) | (8,753,061) |
| Deemed dividends on Series C and D Preferred Stock | (98,609) | 0 | (162,238) | 0 |
| NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS | $ (5,496,273) | $ (4,930,202) | $ (9,006,526) | $ (8,753,061) |
| Basic and diluted loss per share | $ (0.07) | $ (0.10) | $ (0.11) | $ (0.18) |
| Weighted average shares of common stock outstanding- basic and diluted | 81,766,128 | 48,207,937 | 81,428,231 | 48,197,581 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest income earned from interest bearing assets classified as other. No definition available.
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|